24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ALS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:11
Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes
17:56
Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock
14:00
Melio names Boaz BenDavid as its first Chief Financial Officer
13:28
Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Nvidia continues Israel shopping spree with acquisition of Deci
3
Nvidia announces $700 million acquisition of Run:ai
4
Nvidia on verge of completing $700 million acquisition of Run:ai
5
Nagomi Security raises $23 million Series A for proactive defense platform
More news
ALS
5 stories about ALS
NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI
28.07.22
|
CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
Mind over Matter: The man who turned himself into a cyborg to overcome ALS
13.09.20
|
Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
05.08.19
|
Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
05.02.18
|
Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases
Please ensure Javascript is enabled for purposes of
website accessibility